Quantitative motor unit potential analysis and nerve conduction studies for detection of subclinical peripheral nerve dysfunction in patients with compensated liver cirrhosis

Table 6 Correlation between clinical, laboratory profile, and electrodiagnostic findings of the patients

		NESS	RULNML	LULNMC	LULNSL	LULNSC	LULNSA	LPERMC	RFDID	RFDIP	LEHLD	LEHLP
Age	r	.308*	0.202	− 0.148	0.225	− 0.239	− .310*	− .340*	− 0.101	.337*	0.014	.283*
	P	0.03	0.160	0.306	0.116	0.095	0.029	0.016	0.488	0.018	0.921	0.047
	n	50	50	50	50	50	50	50	49	49	50	50
Albumin	r	− .440**	− .372**	.418**	− .381**	.374**	0.203	.442**	− .344*	− 0.255	0.004	− 0.141
	P	0.001	0.008	0.002	0.006	0.007	0.157	0.001	0.015	0.077	0.980	0.328
	n	50	50	50	50	50	50	50	49	49	50	50
Bilirubin	r	− 0.057	− 0.008	0.046	− 0.164	0.249	0.178	0.058	0.103	0.013	0.087	− 0.086
	P	0.693	0.958	0.750	0.256	0.081	0.217	0.690	0.483	0.929	0.547	0.553
	n	50	50	50	50	50	50	50	49	49	50	50
Platelets	r	− .280*	− 0.121	.343*	0.041	0.051	0.245	.282*	− 0.125	− 0.023	0.074	− 0.101
	P	0.049	0.401	0.015	0.778	0.726	0.086	0.047	0.393	0.876	0.609	0.487
	n	50	50	50	50	50	50	50	49	49	50	50
Child score	r	.309*	0.123	− 0.177	0.053	− 0.099	− 0.100	− .282*	0.200	0.232	− 0.158	0.127
	P	0.029	0.394	0.219	0.716	0.493	0.490	0.048	0.167	0.109	0.273	0.381
	n	50	50	50	50	50	50	50	49	49	50	50
ALBI score	r	− .339*	− .318*	.383**	− 0.251	.281*	0.142	.354*	− 0.187	− 0.152	0.023	− 0.177
	P	0.016	0.024	0.006	0.079	0.048	0.325	0.012	0.198	0.296	0.874	0.220
	n	50	50	50	50	50	50	50	49	49	50	50

NESS, neuropathy electrodiagnostic severity score; RULNML, right ulnar motor latency; LULNMC, left ulnar motor conduction velocity; LULNSL, left ulnar sensory latency; LULNSC, left ulnar sensory conduction velocity; LULNSA, left ulnar sensory amplitude; LPERMC, left peroneal motor conduction velocity; RFDID, right first dorsal interosseous duration, RFDIP, right first dorsal interosseous phases; LEHLD, left extensor hallucis longus duration; LEHLP, left extensor hallucis longus phases; ALT, alanine transaminase; AST, aspartate; INR, international normalized ratio; BMI, body mass index; NSC, neuropathy symptom and change; ALBI, albumin-bilirubin; r, correlation coefficient
* Correlation is significant at the 0.05 level, ** Correlation is significant at the 0.01 level